NASDAQ NMS - GLOBAL MARKET · VRXA
-0.68% · -$0.0100 · Vol 16.4K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Veraxa Biotech AG

Veraxa Biotech AG

Biotechnology
$1.46
Card
Relationship Map

Follow $VRXA

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $VRXA by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · No analyst covers this company
VRXA
Veraxa Biotech AG
Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Lowest range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

23/ 100
Veridion Score
Lowest range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4 of 6 factors measured · Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is VRXA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading VRXA catalysts
About Veraxa Biotech AG
Biotechnology
Listed since
2026
Country
CH

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.50
Day high
$1.52
Day low
$1.45
Previous close
$1.47
52W high
$24.79
-94.11% from high
52W low
$1.35
0% of range
Market cap
$55.7M
P/E
25.96×
EPS
$0.2842
Beta
3.28
Shares out
141.4M
Volume
16.4K
0.05× rel vol
Avg volume
300.4K
VWAP
$1.47
Price history computed in-house
1W
-11.52%
1M
-22.75%
3M
-67.41%
SMA 50 $1.80 · below
SMA 200 Not reported · Not reported
52W position 0%

VRXA overview

Veridion Score
23
Registered · 2026-09-18
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around VRXA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading VRXA Form 4 filings
Public disclosures

Congress activity in VRXA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for VRXA in the cached public ledger.

Federal contracts

VRXA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for VRXA in this window.
Lobbying spend

VRXA lobbying filings, year to date.

Registered lobbying filings matched to Veraxa Biotech AG.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for VRXA in this window.
Loading news for VRXA
Analyst ratings
Sovereign unlock shows live analyst consensus for VRXA.
Options
Sovereign unlock shows live options positioning for VRXA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.